Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Altered molecular repertoire of immune system by renal dysfunction in the elderly: is prediction and targeted prevention in the horizon?

Lang CL, Wang MH, Hung KY, Chiang CK, Lu KC.

EPMA J. 2013 Jun 21;4(1):17. doi: 10.1186/1878-5085-4-17. eCollection 2013 Jun 21.

2.

Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients.

Libetta C, Rampino T, Dal Canton A.

Am J Kidney Dis. 2001 Aug;38(2):286-95.

PMID:
11479154
4.

T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients.

Sester U, Sester M, Hauk M, Kaul H, Köhler H, Girndt M.

Nephrol Dial Transplant. 2000 Aug;15(8):1217-23.

PMID:
10910448
5.

Plasma levels of Th1/Th2 type cytokine are associated with change of prolactin and GH/IGF-I in hemodialysis patients.

Liu ML, Xu G, Xue SR, Zhong XC, Chen GX, Chen ZJ.

Int J Artif Organs. 2008 Apr;31(4):303-8.

PMID:
18432585
6.

Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.

Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.

Nephron Clin Pract. 2008;110(1):c58-65. doi: 10.1159/000151534. Epub 2008 Aug 25.

PMID:
18724068
7.

[Influence of erythropoietin on immunological system of patients with chronic renal failure].

Debska-Slizień A, Rutkowski B, Manitius J, Zdrojewski Z, Szołkiewicz M, Bułło B, Lizakowski S, Myśliwska J, Myśliwski A, Bryl E, Trzonkowski P, Bakowska A, Rachoń D.

Pol Merkur Lekarski. 2003 Oct;15(88):326-7; discussion 327-9. Polish.

PMID:
14974359
8.

Pathogenesis and treatment of secondary hyperparathyroidism in dialysis patients: the role of paricalcitol.

Cozzolino M, Galassi A, Gallieni M, Brancaccio D.

Curr Vasc Pharmacol. 2008 Apr;6(2):148-53. Review.

PMID:
18393917
9.

Vitamin D modulates peripheral immunity in patients with Behçet's disease.

Hamzaoui K, Ben Dhifallah I, Karray E, Sassi FH, Hamzaoui A.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl 60):S50-7. Epub 2010 Sep 24.

PMID:
20868571
10.

Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.

Jean G, Souberbielle JC, Chazot C.

Nephrol Dial Transplant. 2009 Dec;24(12):3799-805. doi: 10.1093/ndt/gfp370. Epub 2009 Jul 21.

PMID:
19622574
11.

[Severe 25-OH vitamin D deficiency in patients on chronic hemodialysis].

Marinelli A, Pistolesi V, Rossi V, Battista M, Buono A, Della Grotta F, Di Napoli A.

G Ital Nefrol. 2014 Sep-Oct;31(5). pii: gin/31.5.7. Italian.

12.

The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients.

Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T, Stülten C, van der Kuip H, Pauli-Magnus C, Raub U, Kuhlmann U, Mettang T.

Nephrol Dial Transplant. 2006 Mar;21(3):749-55. Epub 2005 Oct 25.

PMID:
16249205
13.

T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.

Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Díaz PV.

Pediatrics. 2006 May;117(5):e878-86. Epub 2006 Apr 17.

PMID:
16618789
15.

Characteristic cytokine products of Th1 and Th2 cells in hemodialysis patients.

Daichou Y, Kurashige S, Hashimoto S, Suzuki S.

Nephron. 1999;83(3):237-45.

PMID:
10529630
16.

Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.

Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR.

Hemodial Int. 2007 Jul;11(3):315-21.

PMID:
17576296
17.

Vitamin D receptor agonist supplementation and suppression of inflammation may have advantage for all-cause mortality in hemodialysis patients.

Ogawa T, Kyono A, Sato M, Sugimoto H, Otsuka K, Nitta K.

Clin Exp Nephrol. 2012 Oct;16(5):779-85. doi: 10.1007/s10157-012-0626-2. Epub 2012 Mar 29.

PMID:
22457088
18.

Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.

Bucharles S, Barberato SH, Stinghen AE, Gruber B, Piekala L, Dambiski AC, Custodio MR, Pecoits-Filho R.

J Ren Nutr. 2012 Mar;22(2):284-91. doi: 10.1053/j.jrn.2011.07.001. Epub 2011 Sep 10.

PMID:
21908203
19.

[Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy].

Jean G, Vanel T, Terrat JC, Hurot JM, Lorriaux C, Mayor B, Deleaval P, Vovan C, Chazot C.

Nephrol Ther. 2010 Apr;6(2):105-10. doi: 10.1016/j.nephro.2009.12.004. Epub 2010 Feb 24. French.

PMID:
20185380
20.

VDR FokI polymorphism is associated with a reduced T-helper cell population under vitamin D stimulation in type 1 diabetes patients.

Morán-Auth Y, Penna-Martinez M, Badenhoop K.

J Steroid Biochem Mol Biol. 2015 Apr;148:184-6. doi: 10.1016/j.jsbmb.2015.01.003. Epub 2015 Jan 7.

PMID:
25576905

Supplemental Content

Support Center